The study objectives were to compare the HDL functions between healthy controls and patients presenting with acute coronary syndrome, evaluate the changes in the functional parameters after six months of treatment followed by an assessment of the relationship of both CEC and PON1 activity with HDL-cholesterol and Apo A-I. This evidence concerns the gene PON1 and acute coronary syndrome.